|
DE69635496T2
(de)
|
1995-09-15 |
2006-07-27 |
Gerding, Dale N., Chicago |
Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
KR101312745B1
(ko)
|
2005-03-03 |
2013-09-27 |
가부시키가이샤 메이지 |
면역기능 조정제
|
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
|
|
GB0916335D0
(en)
*
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
ES2730828T3
(es)
*
|
2010-02-01 |
2019-11-12 |
Rebiotix Inc |
Bacterioterapia para la colitis por Clostridium difficile
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
PH12013500224A1
(en)
|
2010-08-04 |
2013-04-08 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2012162335A2
(en)
|
2011-05-23 |
2012-11-29 |
Washington State University Research Foundation |
Use of photosynthetic pigment stabilizing agents to regulate ripening and quality in fruits and vegetables
|
|
ES2662793T3
(es)
|
2011-09-14 |
2018-04-09 |
Nubiyota Llc |
Complementos de medio y métodos para cultivar microorganismos anaerobios gastrointestinales humanos
|
|
CN116942833A
(zh)
|
2011-12-01 |
2023-10-27 |
国立大学法人 东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
|
IN2014DN07752A
(https=)
|
2012-02-29 |
2015-05-15 |
Ethicon Endo Surgery Inc |
|
|
WO2013146319A1
(ja)
|
2012-03-30 |
2013-10-03 |
味の素株式会社 |
糖尿病誘起細菌
|
|
EP3686284A1
(en)
|
2012-05-18 |
2020-07-29 |
Genome Research Limited |
Methods and groups
|
|
CN106620189B
(zh)
|
2012-06-06 |
2021-11-19 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
CA3212215A1
(en)
|
2012-11-23 |
2014-05-30 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
CA2899925A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
|
AU2014239883B2
(en)
*
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
EP2967077A4
(en)
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
|
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
AU2014331610B2
(en)
|
2013-10-03 |
2019-11-07 |
Trustees Of The University Of Pennsylvania |
Compositions comprising a defined microbiome and methods of use thereof
|
|
EP3074027B1
(en)
|
2013-11-25 |
2024-12-18 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
JP6617935B2
(ja)
|
2014-04-10 |
2019-12-11 |
国立研究開発法人理化学研究所 |
Ｔｈ１７細胞の誘導のための組成物及び方法
|
|
WO2015164555A1
(en)
|
2014-04-23 |
2015-10-29 |
Cornell University |
Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
|
|
PT3146065T
(pt)
|
2014-05-19 |
2025-01-14 |
Memorial Sloan Kettering Cancer Center |
Métodos e composições para reduzir a infecção por clostridium difficile
|
|
SG10201903823QA
(en)
|
2014-10-31 |
2019-05-30 |
Whole Biome Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
CA3254897A1
(en)
|
2014-11-25 |
2026-03-02 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
CA2985827A1
(en)
|
2015-05-14 |
2016-11-17 |
Crestovo Holdings Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
BR112017024928A2
(pt)
|
2015-05-21 |
2018-07-31 |
Yeda Research And Development Co Ltd |
Métodos para prevenção da diabetes ou pré- diabetes em um indivíduo, para melhoria da resposta à glicose em um indivíduo com intolerância à glicose, para manutenção da resposta à glicose em um indivíduo com tolerância à glicose e para melhoria da saúde de um indivíduo, composição probiótica e composição farmacêutica
|
|
US20180153944A1
(en)
|
2015-06-09 |
2018-06-07 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
HRP20191949T1
(hr)
|
2015-06-15 |
2020-01-24 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
ME03511B
(me)
|
2015-06-15 |
2020-04-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
WO2016203221A1
(en)
|
2015-06-15 |
2016-12-22 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
WO2016209806A1
(en)
|
2015-06-22 |
2016-12-29 |
President And Fellows Of Harvard College |
Induction of lamina propria regulatory t cells
|
|
JP2018524354A
(ja)
|
2015-07-08 |
2018-08-30 |
セレス セラピューティクス インコーポレイテッド |
大腸炎を処置する方法
|
|
CN108289917A
(zh)
|
2015-08-24 |
2018-07-17 |
努比约塔有限公司 |
使用粪源细菌群落来治疗微生态失衡的系统和方法
|
|
BR112018008358A2
(pt)
|
2015-10-26 |
2019-04-24 |
Crestovo Holdings Llc |
?composições e métodos para terapia relacionada à microbiota fecal?
|
|
HK1254843B
(zh)
|
2015-11-20 |
2020-04-17 |
希杰生物科技株式会社 |
包含细菌菌株的组合物
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
US20190247447A1
(en)
|
2015-11-24 |
2019-08-15 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
SG10201913557TA
(en)
|
2016-03-04 |
2020-02-27 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
|
US20170290889A1
(en)
|
2016-04-11 |
2017-10-12 |
New York University |
Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
|
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
JP7168558B2
(ja)
*
|
2016-06-14 |
2022-11-09 |
ヴェダンタ バイオサイエンシーズ インコーポレーテッド |
Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
|
|
WO2018005606A1
(en)
*
|
2016-06-28 |
2018-01-04 |
Synthetic Biologics, Inc. |
Microbiome protection from oral antibiotics
|
|
WO2018080477A1
(en)
|
2016-10-26 |
2018-05-03 |
The Joan & Irwin Jacobs Technion-Cornell Institute |
Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols
|
|
JP2021524476A
(ja)
|
2018-05-24 |
2021-09-13 |
セレス セラピューティクス インコーポレイテッド |
設計された細菌組成物及びその使用
|
|
WO2020037271A1
(en)
|
2018-08-17 |
2020-02-20 |
Vedanta Biosciences, Inc. |
Methods of decreasing dysbiosis and restoring a microbiome
|
|
WO2022159711A1
(en)
|
2021-01-21 |
2022-07-28 |
Vedanta Biosciences, Inc. |
Compositions and methods for treating hepatic encephalopathy
|